MGMT immunoexpression in adamantinomatous craniopharyngiomas.

about

MGMT immunoexpression in adamantinomatous craniopharyngiomas.

Item

http://www.wikidata.org/entity/Q44751918

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

MGMT immunoexpression in adamantinomatous craniopharyngiomas.

@en

MGMT immunoexpression in adamantinomatous craniopharyngiomas.

@nl

type

Item

label

MGMT immunoexpression in adamantinomatous craniopharyngiomas.

@en

MGMT immunoexpression in adamantinomatous craniopharyngiomas.

@nl

prefLabel

MGMT immunoexpression in adamantinomatous craniopharyngiomas.

@en

MGMT immunoexpression in adamantinomatous craniopharyngiomas.

@nl

P1476

MGMT immunoexpression in adamantinomatous craniopharyngiomas.

@en

P2093

Ahmet Murat Müslüman

http://www.w3.org/2001/XMLSchema#string

Ayşenur Ozderya

http://www.w3.org/2001/XMLSchema#string

Canan Tanık

http://www.w3.org/2001/XMLSchema#string

Feyza Yener Oztürk

http://www.w3.org/2001/XMLSchema#string

Hanife Ozkayalar

http://www.w3.org/2001/XMLSchema#string

Ozcan Karaman

http://www.w3.org/2001/XMLSchema#string

Sayid Shafi Zuhur

http://www.w3.org/2001/XMLSchema#string

Yunus Aydın

http://www.w3.org/2001/XMLSchema#string

Yüksel Altuntaş

http://www.w3.org/2001/XMLSchema#string

P2860

Craniopharyngioma

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications.

MGMT: its role in cancer aetiology and cancer therapeutics.

Craniopharyngiomas.

New developments in the treatment of malignant gliomas.

Repeat operations in pediatric patients with recurrent craniopharyngiomas.

Intracystic treatments for craniopharyngioma.

O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.

High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease.

P2888

s11102-011-0297-0

P304

323-327

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11102-011-0297-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21318329

http://www.w3.org/2001/XMLSchema#string

P921

craniopharyngioma